MADISON, N.J., March 1 /PRNewswire-FirstCall/ -- Wyeth announced today that the jury in the case of Patricia Geers v. Wyeth in U.S. District Court for the Western District of Texas in Midland found in favor of Wyeth.
“We are pleased with the verdict and with the jury’s determination that Wyeth acted appropriately at all times,” says Patrick Mizell, an attorney from Vinson & Elkins, who represented Wyeth.
The plaintiff was represented by the firm of George Fleming & Associates of Houston, Texas.
The trial began on February 21, 2006 before The Honorable Harry Hudspeth. The plaintiff alleged heart valve injury from the use of the diet drug Pondimin, a product once marketed by Wyeth.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Wyeth
CONTACT: Media: Douglas Petkus, +1-973-660-5218, or Investors: JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com//
